In this case study, Xstrahl 150 was used to treat two patients with Cutaneous Squamous Cell Carcinoma.
Cutaneous Squamous Cell Carcinoma Case Study
read more
Radiation Therapy
RADiant in Action: The Dermatology & Laser Center of San Antonio
Over his career, Dr. Steven Davis, medical director of The Dermatology & Laser Center of San Antonio, has performed more than 25,000 skin cancer operations. While surgery is still the primary treatment, it's not always the best option for the patient, especially...
Dermatologist Highlights RADiant Benefits
Over his career, Dr. Steven Davis, medical director of The Dermatology & Laser Center of San Antonio has performed over 25,000 skin cancer operations. While surgery is still the primary treatment, it's not always the best option for the patient, especially people...
RADiant Treatment Case Study: Basal Cell Carcinoma
Check out this case study to see the great outcome of a basal cell carcinoma patient thanks to treatment with the RADiant system. See the full case study below.
RADiant to Exhibit at the 2019 American Society for Dermatologic Surgery (ASDS) Annual Meeting in Chicago, IL
Xstrahl Medical, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological conditions, is featuring its RADiant treatment system at the annual American Society for Dermatologic Surgery (ASDS) Annual Meeting in Chicago, IL...
Xstrahl 150 Used as System of Choice for Australian Case Study Reviews
With the rates of skin cancers ever increasing, especially in places with high sun prevalence, treatment of these conditions can cause not only a demand on resources, but there is a lack of unified response and the best way to treat. This is why Prof. Gerald Fogarty...
Xstrahl Spotlights New RADiant Treatment System at CalDerm 2019
Xstrahl Medical, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological conditions, is featuring its RADiant treatment system at the annual California Society of Dermatology symposium in Santa Barbara from September...
Xstrahl in Action: Xstrahl 200 Used for Research into Clinical Response Following Superficial Radiation Therapy of SCCs
Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin cancer and arises from abnormal growth in the squamous cells of the skin’s outermost layer due to cumulative exposure to ultraviolet radiation. Without treatment, cSCC can be...
Xstrahl in Action: Xstrahl 200 Used for Tissue Conservation and Long-Term Control of Melanoma
In their paper “Xstrahl therapy results in tissue conservation and long-term control of melanoma in situ of the lower eyelid” Gerald B Fogarty, Amy Ziebell, Stephanie Nicholls, Susith Kulasekara, Doug Duthie and Krishna Tumuluri present the case of a middle-aged woman...
Contact Us